Inter Pharma PCL (IP.BK) Stock Price
Inter Pharma PCL Price
Revenue has compounded at 44.3% per year over the past 10 years to 2.19 B THB. Earnings per share have declined at 17.5% per year over the last 10 years. Inter Pharma PCL's net margin stands at 5.6%, down from 11.6% several years earlier. Inter Pharma PCL currently offers a dividend yield of about 0.71%. The payout ratio is around 57% of earnings. Analysts set a median price target of 10.04 THB, implying 104.1% above the current price. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.
Inter Pharma PCL stock price
Inter Pharma PCL business model & stock analysis
Frequently asked questions about Inter Pharma PCL
Analysts currently set an average price target of 10.04 THB for the Inter Pharma PCL stock (median: 10.04 THB), implying +104.1 % versus the latest price. The consensus is based on 9 analyst ratings.
9 analysts currently rate the Inter Pharma PCL stock: 8 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Inter Pharma PCL share trades at 0.13 EUR (4.92 THB).
The revenue cannot currently be calculated for Inter Pharma PCL.
The profit cannot currently be calculated for Inter Pharma PCL.
The P/E ratio cannot be calculated for Inter Pharma PCL at the moment.
The P/S cannot be calculated for Inter Pharma PCL currently.
The Eulerpool Quality Score for Inter Pharma PCL is 5/10.
The ISIN of Inter Pharma PCL is TH9474010005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Inter Pharma PCL is IP.BK. The ticker symbol is used to trade Inter Pharma PCL shares on the stock exchange.
Inter Pharma PCL stock
Inter Pharma PCL Peer Group
Inter Pharma PCL FIGI
All fundamentals and in-depth analysis of Inter Pharma PCL
Our stock analysis for Inter Pharma PCL stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inter Pharma PCL. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.